ReP USP - Resultado da busca

Trabalho de evento-resumo
Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia (2023)
Toscano, Luis Felipe ; Vargas, Leticia; Bezerra, Thiago; Ribeiro, Deidiane Elisa ; Ulrich, Henning ; Salum, Cristiane Otero Reis
Source: Anais. Conference titles: Reunião Anual da Federação de Sociedade de Biologia Experimental/FeSBE. Unidade: IQ
Subjects: ANTIOXIDANTES, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOSCANO, Luis Felipe et al. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia. 2023, Anais.. São Paulo: Sociedade Brasileira de Biociências Nucleares/SBBN, 2023. Disponível em: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br. Acesso em: 08 out. 2024.
APA
Toscano, L. F., Vargas, L., Bezerra, T., Ribeiro, D. E., Ulrich, H., & Salum, C. O. R. (2023). Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia. In Anais. São Paulo: Sociedade Brasileira de Biociências Nucleares/SBBN. Recuperado de https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br
NLM
Toscano LF, Vargas L, Bezerra T, Ribeiro DE, Ulrich H, Salum COR. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia [Internet]. Anais. 2023 ;[citado 2024 out. 08 ] Available from: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br
Vancouver
Toscano LF, Vargas L, Bezerra T, Ribeiro DE, Ulrich H, Salum COR. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia [Internet]. Anais. 2023 ;[citado 2024 out. 08 ] Available from: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br
Artigo de periodico
Various facets of excitotoxicity (2022)
Glaser, Talita ; Silva, Jean Bezerra ; Juvenal, Guilherme Araújo ; Maiolini, Pedro Negrão; Turrini, Natalia ; Petiz, Lyvia Lintzmaier ; Marques, Lucas Bonfim; Ribeiro, Deidiane Elisa ; Ye, Qing; Tang, Yong ; Ulrich, Henning
Source: Exploration of Neuroprotective Therapy. Unidade: IQ
Subjects: MITOCÔNDRIAS, AMINOÁCIDOS EXCITATÓRIOS, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, v. 2, p. 36–64, 2022Tradução . . Disponível em: https://doi.org/10.37349/ent.2022.00017. Acesso em: 08 out. 2024.
APA
Glaser, T., Silva, J. B., Juvenal, G. A., Maiolini, P. N., Turrini, N., Petiz, L. L., et al. (2022). Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, 2, 36–64. doi:10.37349/ent.2022.00017
NLM
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 out. 08 ] Available from: https://doi.org/10.37349/ent.2022.00017
Vancouver
Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 out. 08 ] Available from: https://doi.org/10.37349/ent.2022.00017
Artigo de periodico
Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease (2022)
Campos, Henrique C; Ribeiro, Deidiane Elisa ; Hashiguchi, Debora ; Hukuda, Deborah Y ; Gimenes, Christiane; Romariz, Simone A. A; Ye, Qing; Tang, Yong ; Ulrich, Henning ; Longo, Beatriz Monteiro
Source: Stem Cell Reviews and Reports. Unidade: IQ
Subjects: CÉLULAS-TRONCO, DOENÇA DE ALZHEIMER, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Henrique C et al. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, v. 18, p. 781–791, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12015-021-10321-9. Acesso em: 08 out. 2024.
APA
Campos, H. C., Ribeiro, D. E., Hashiguchi, D., Hukuda, D. Y., Gimenes, C., Romariz, S. A. A., et al. (2022). Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, 18, 781–791. doi:10.1007/s12015-021-10321-9
NLM
Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 out. 08 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
Vancouver
Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 out. 08 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
Artigo de jornal-dep/entr
Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires] (2021)
Ulrich, Henning ; Ribeiro, Deidiane Elisa ; Giacomelli, Ágatha Oliveira
Source: Jornal da USP. Unidade: IQ
Subjects: CORONAVIRUS, COVID-19, CÉREBRO, SISTEMA NERVOSO CENTRAL, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULRICH, Henning e RIBEIRO, Deidiane Elisa e GIACOMELLI, Ágatha Oliveira. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]. Jornal da USP. São Paulo: Instituto de Química, Universidade de São Paulo. Disponível em: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos. Acesso em: 08 out. 2024. , 2021
APA
Ulrich, H., Ribeiro, D. E., & Giacomelli, Á. O. (2021). Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]. Jornal da USP. São Paulo: Instituto de Química, Universidade de São Paulo. Recuperado de https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
NLM
Ulrich H, Ribeiro DE, Giacomelli ÁO. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires] [Internet]. Jornal da USP. 2021 ;[citado 2024 out. 08 ] Available from: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
Vancouver
Ulrich H, Ribeiro DE, Giacomelli ÁO. Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires] [Internet]. Jornal da USP. 2021 ;[citado 2024 out. 08 ] Available from: https://jornal.usp.br/ciencias/coronavirus-no-cerebro-drogas-que-bloqueiam-receptor-poderiam-prevenir-ou-tratar-problemas-neurologicos
Artigo de periodico
Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases (2021)
Glaser, Talita ; Giacomelli, Ágatha Oliveira ; Petiz, Lyvia Lintzmaier ; Ribeiro, Deidiane Elisa ; Andrejew, Roberta ; Ulrich, Henning
Source: Frontiers in Pharmacology. Unidade: IQ
Subjects: DOENÇAS NEURODEGENERATIVAS, RECEPTORES, ANTAGONISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, v. 12, p. 1-7 art. 659097, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.659097. Acesso em: 08 out. 2024.
APA
Glaser, T., Giacomelli, Á. O., Petiz, L. L., Ribeiro, D. E., Andrejew, R., & Ulrich, H. (2021). Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases. Frontiers in Pharmacology, 12, 1-7 art. 659097. doi:10.3389/fphar.2021.659097
NLM
Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fphar.2021.659097
Vancouver
Glaser T, Giacomelli ÁO, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-7 art. 659097.[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fphar.2021.659097
Artigo de periodico
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021)
Ribeiro, Deidiane Elisa ; Giacomelli, Ágatha Oliveira ; Glaser, Talita ; Sampaio, Vanessa Fernandes Arnaud ; Andrejew, Roberta ; Dieckmann, Luiz; Baranova, Juliana; Lameu, Claudiana ; Ratajczak, Mariusz Z; Ulrich, Henning
Source: Molecular Psychiatry. Unidade: IQ
Subjects: COVID-19, RECEPTORES, SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, v. 26, p. 1044–1059, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41380-020-00965-3. Acesso em: 08 out. 2024.
APA
Ribeiro, D. E., Giacomelli, Á. O., Glaser, T., Sampaio, V. F. A., Andrejew, R., Dieckmann, L., et al. (2021). Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, 26, 1044–1059. doi:10.1038/s41380-020-00965-3
NLM
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2024 out. 08 ] Available from: https://doi.org/10.1038/s41380-020-00965-3
Vancouver
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2024 out. 08 ] Available from: https://doi.org/10.1038/s41380-020-00965-3
Artigo de periodico
The P2X7 receptor: central hub of brain diseases (2020)
Andrejew, Roberta ; Giacomelli, Ágatha Oliveira ; Ribeiro, Deidiane Elisa ; Glaser, Talita ; Sampaio, Vanessa Fernandes Arnaud ; Lameu, Claudiana ; Ulrich, Henning
Source: Frontiers in Molecular Neuroscience. Unidade: IQ
Subjects: DOENÇAS CEREBRAIS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREJEW, Roberta et al. The P2X7 receptor: central hub of brain diseases. Frontiers in Molecular Neuroscience, v. 13, p. 1-27 art. 124, 2020Tradução . . Disponível em: https://doi.org/10.3389/fnmol.2020.00124. Acesso em: 08 out. 2024.
APA
Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Glaser, T., Sampaio, V. F. A., Lameu, C., & Ulrich, H. (2020). The P2X7 receptor: central hub of brain diseases. Frontiers in Molecular Neuroscience, 13, 1-27 art. 124. doi:10.3389/fnmol.2020.00124
NLM
Andrejew R, Giacomelli ÁO, Ribeiro DE, Glaser T, Sampaio VFA, Lameu C, Ulrich H. The P2X7 receptor: central hub of brain diseases [Internet]. Frontiers in Molecular Neuroscience. 2020 ; 13 1-27 art. 124.[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fnmol.2020.00124
Vancouver
Andrejew R, Giacomelli ÁO, Ribeiro DE, Glaser T, Sampaio VFA, Lameu C, Ulrich H. The P2X7 receptor: central hub of brain diseases [Internet]. Frontiers in Molecular Neuroscience. 2020 ; 13 1-27 art. 124.[citado 2024 out. 08 ] Available from: https://doi.org/10.3389/fnmol.2020.00124
Artigo de periodico
Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease (2020)
Glaser, Talita ; Andrejew, Roberta ; Giacomelli, Ágatha Oliveira ; Ribeiro, Deidiane Elisa ; Marques, Lucas Bonfim; Ye, Qing; Ren, Wen-Jing; Semyanov, Alexey; Illes, Peter; Tang, Yong; Ulrich, Henning
Source: Neuroscience Bulletin. Unidade: IQ
Subjects: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 08 out. 2024.
APA
Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
NLM
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 08 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
Vancouver
Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 08 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
Artigo de periodico
P2X7 receptor signaling in stress and depression (2019)
Ribeiro, Deidiane Elisa ; Roncalho, Aline ; Glaser, Talita ; Ulrich, Henning ; Wegener, Gregers; Wegener, Sâmia Regiane Lourenço Joca
Source: International Journal of Molecular Sciences. Unidades: IQ, FCFRP
Subjects: DEPRESSÃO, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. P2X7 receptor signaling in stress and depression. International Journal of Molecular Sciences, v. 20, n. 11, p. 1-26 art. 2778, 2019Tradução . . Disponível em: https://doi.org/10.3390/ijms20112778. Acesso em: 08 out. 2024.
APA
Ribeiro, D. E., Roncalho, A., Glaser, T., Ulrich, H., Wegener, G., & Wegener, S. R. L. J. (2019). P2X7 receptor signaling in stress and depression. International Journal of Molecular Sciences, 20( 11), 1-26 art. 2778. doi:10.3390/ijms20112778
NLM
Ribeiro DE, Roncalho A, Glaser T, Ulrich H, Wegener G, Wegener SRLJ. P2X7 receptor signaling in stress and depression [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 11): 1-26 art. 2778.[citado 2024 out. 08 ] Available from: https://doi.org/10.3390/ijms20112778
Vancouver
Ribeiro DE, Roncalho A, Glaser T, Ulrich H, Wegener G, Wegener SRLJ. P2X7 receptor signaling in stress and depression [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 11): 1-26 art. 2778.[citado 2024 out. 08 ] Available from: https://doi.org/10.3390/ijms20112778
Parte de monografia/livro
Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases (2019)
Andrejew, Roberta ; Glaser, Talita ; Giacomelli, Ágatha Oliveira ; Ribeiro, Deidiane Elisa ; Godoy, Mariana Araya de; Granato, Alessandro Eustaquio Campos ; Ulrich, Henning
Source: Stem Cells: Therapeutic Applications. Unidade: IQ
Subjects: DOENÇAS NEURODEGENERATIVAS, DOENÇAS CARDIOVASCULARES, NEUROGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREJEW, Roberta et al. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. Stem Cells: Therapeutic Applications. Tradução . Cham: Springer Nature, 2019. . Disponível em: https://doi.org/10.1007/978-3-030-31206-0_14. Acesso em: 08 out. 2024.
APA
Andrejew, R., Glaser, T., Giacomelli, Á. O., Ribeiro, D. E., Godoy, M. A. de, Granato, A. E. C., & Ulrich, H. (2019). Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. In Stem Cells: Therapeutic Applications. Cham: Springer Nature. doi:10.1007/978-3-030-31206-0_14
NLM
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2024 out. 08 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14
Vancouver
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2024 out. 08 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration